No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Compass Therapeutics Names Barry Shin CFO
Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Trevena Appoints Katrine Sutton as New CFO
Trevena Cut to Neutral From Buy by HC Wainwright & Co.
Trevena Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Trevena Analyst Ratings